Sweden · Delayed Price · Currency is SEK Xvivo Perfusion AB Statistics
Total Valuation
STO:XVIVO has a market cap or net worth of SEK 7.41 billion. The enterprise value is 7.23 billion.
| Market Cap | 7.41B |
| Enterprise Value | 7.23B |
Important Dates
The last earnings date was Tuesday, July 14, 2026.
| Earnings Date | Jul 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XVIVO has 31.50 million shares outstanding. The number of shares has decreased by -0.43% in one year.
| Current Share Class | 31.50M |
| Shares Outstanding | 31.50M |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 28.84% |
| Float | 25.13M |
Valuation Ratios
The trailing PE ratio is 83.65 and the forward PE ratio is 47.73.
| PE Ratio | 83.65 |
| Forward PE | 47.73 |
| PS Ratio | 8.28 |
| PB Ratio | 3.37 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | 42.89 |
| P/OCF Ratio | 31.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 64.71, with an EV/FCF ratio of 41.83.
| EV / Earnings | 81.58 |
| EV / Sales | 8.07 |
| EV / EBITDA | 64.71 |
| EV / EBIT | 64.71 |
| EV / FCF | 41.83 |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.86 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 1.09 |
| Debt / FCF | 0.70 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.13% and return on invested capital (ROIC) is 3.96%.
| Return on Equity (ROE) | 4.13% |
| Return on Assets (ROA) | 2.99% |
| Return on Invested Capital (ROIC) | 3.96% |
| Return on Capital Employed (ROCE) | 4.78% |
| Weighted Average Cost of Capital (WACC) | 12.07% |
| Revenue Per Employee | 4.54M |
| Profits Per Employee | 449,594 |
| Employee Count | 197 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.00 |
Taxes
In the past 12 months, STO:XVIVO has paid 42.94 million in taxes.
| Income Tax | 42.94M |
| Effective Tax Rate | 32.65% |
Stock Price Statistics
The stock price has increased by +7.99% in the last 52 weeks. The beta is 1.46, so STO:XVIVO's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +7.99% |
| 50-Day Moving Average | 267.66 |
| 200-Day Moving Average | 219.77 |
| Relative Strength Index (RSI) | 38.39 |
| Average Volume (20 Days) | 73,803 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:XVIVO had revenue of SEK 895.23 million and earned 88.57 million in profits. Earnings per share was 2.81.
| Revenue | 895.23M |
| Gross Profit | 647.00M |
| Operating Income | 117.70M |
| Pretax Income | 131.51M |
| Net Income | 88.57M |
| EBITDA | 111.66M |
| EBIT | 111.66M |
| Earnings Per Share (EPS) | 2.81 |
Balance Sheet
The company has 304.97 million in cash and 121.62 million in debt, with a net cash position of 183.35 million or 5.82 per share.
| Cash & Cash Equivalents | 304.97M |
| Total Debt | 121.62M |
| Net Cash | 183.35M |
| Net Cash Per Share | 5.82 |
| Equity (Book Value) | 2.20B |
| Book Value Per Share | 69.85 |
| Working Capital | 540.02M |
Cash Flow
In the last 12 months, operating cash flow was 236.35 million and capital expenditures -63.62 million, giving a free cash flow of 172.73 million.
| Operating Cash Flow | 236.35M |
| Capital Expenditures | -63.62M |
| Depreciation & Amortization | 40.56M |
| Net Borrowing | 72.25M |
| Free Cash Flow | 172.73M |
| FCF Per Share | 5.48 |
Margins
Gross margin is 72.27%, with operating and profit margins of 13.15% and 9.89%.
| Gross Margin | 72.27% |
| Operating Margin | 13.15% |
| Pretax Margin | 14.69% |
| Profit Margin | 9.89% |
| EBITDA Margin | 12.47% |
| EBIT Margin | 12.47% |
| FCF Margin | 19.29% |
Dividends & Yields
STO:XVIVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.43% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 1.20% |
| FCF Yield | 2.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for STO:XVIVO is 337.40, which is 43.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 337.40 |
| Price Target Difference | 43.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 25.14% |
| EPS Growth Forecast (3Y) | 124.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:XVIVO has an Altman Z-Score of 13.2 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.2 |
| Piotroski F-Score | 5 |